
How does Alzheimer's disease affect the whole body?
Research shows that Alzheimer's disease affects many organs beyond the nervous system.Alzheimer's is characterized by a buildup of proteins in the brain, which disrupts their function.
A new study in fruit flies shows that these proteins may also significantly impact the functioning of other organs.
The researchers also identified mechanisms that might explain how proteins in the brain can have such wide-reaching effects.
A new study in fruit flies concludes that proteins associated with Alzheimer's disease not only influence brain health, but also have effects further afield.
Specifically, the researchers show that certain Alzheimer's-associated proteins can increase the rate of biological aging and influence fat metabolism and reproduction.
They also created an Alzheimer's Disease Fly Cell Atlas (AD-FCA) based on their analysis of 219 cell types in flies that express Alzheimer's-associated proteins in their brains.
The results recently appeared in the journal Neuron .
Alzheimer's and other dementias are considered diseases of the mind, and for good reason. The primary symptoms are cognitive changes that grow progressively more severe as time goes on.
For this reason, much of the research into dementia focuses on the brain and nervous system. However, more recently, scientists have begun exploring Alzheimer's influence on other aspects of the body.
The authors of the new study explain how new evidence hints that the effects of Alzheimer's extend beyond the nervous system to other parts of the body. 'For example,' they write, Alzheimer's 'has been associated with disruptions in the gut microbiota, cardiovascular function, and hormone homeostasis.'
Alzheimer's disease is characterized by a buildup of faulty proteins in the brain, including amyloid-beta 42 and tau.
As they accumulate, they form so-called amyloid plaques and neurofibrillary tangles, respectively. These proteins interfere with how neurons work and, eventually, kill them.
In their recent study, the researchers used fruit flies. Although fruit flies, as you may have noticed, are quite different from humans, they have already provided many insights into human health.
As the researchers write, 'Many molecular pathways are conserved from flies to mammals.'
Medical News Today contacted Gurneet Sawhney, MD, chief neurosurgeon and founder at Neurolife Brain and Spine Clinic, who was not involved in the study. We asked about the usefulness of fly models in neuroscience.
'Fruit fly models are surprisingly valuable in dementia research. While they may seem simplistic,' he explained, 'they allow us to study the effects of tau and amyloid at a genetic and cellular level, with faster results and lower complexity than mammalian models.'
'They've helped us uncover fundamental mechanisms of neurodegeneration that often translate into mammalian systems later,' he said.
In the current experiment, the scientists used flies with either amyloid or tau buildup and compared them with control flies without protein buildup.
The researchers employed a technique called whole-organism single-nucleus RNA sequencing . In a nutshell, this involves analyzing genetic information from cell nuclei to discover which genes are turned 'on' in specific cell types.
The authors investigated the impact of tau and amyloid on a range of cell types throughout the flies' bodies.
First, they examined the cells of the nervous system, including brain cells, nerve cells in their body, and glial cells (support cells for neurons).
They found that amyloid resulted in the loss of many types of these cells compared with tau and control flies.
In particular, cells involved with the senses, such as vision, hearing, and smell, were impacted most severely. Interestingly, loss of smell is an early sign of Alzheimer's in humans.
When investigating the mechanism responsible for neuronal cell death, the researchers identified a cluster of neuronal cells that expressed lactate dehydrogenase (LDH). We asked Sawhney why this matters:
'LDH plays a role in cellular energy metabolism,' he explained, 'and its dysregulation can indicate tissue stress or damage. In the context of dementia, abnormal LDH activity might reflect broader metabolic dysfunction.'
Importantly, the scientists also identified increased levels of LDH in the brain tissue from humans with Alzheimer's but not those without the condition. According to Sawhney, this increased LDH may 'link neurodegeneration with systemic effects, as this study hints.'
The scientists also showed that cells with elevated LDH had changes in genes that control mitochondrial functions. This is important because mitochondrial dysfunction is linked to oxidative stress, which is an early feature of Alzheimer's in humans.
Next, the scientists moved their attention to the effects of Alzheimer's proteins on cells other than those of the nervous system. This time, it was tau that produced the most significant changes.
The cell types that were most affected were those involved in fat metabolism, digestion, and reproduction. According to the authors, 'The fly fat body is a central storage depot of nutrients and energy reserves.' It carries out a similar role to the liver, immune system, and fat tissue in mammals.
They found that fat droplets in tau flies are large early on, but become smaller and more fragmented as the disease progresses. The researchers then looked at fat cells in a mouse model of Alzheimer's — the equivalent of the fly's fat droplets. Again, they found oversized fat cells initially, which grew smaller as the disease progressed.
Aside from changes in fat metabolism, the researchers noted changes in the behaviour of cells in the gut. In line with this, studies in mice have also shown that tau induces gut degeneration .
Finally, neuronal tau was associated with a reduced ability to reproduce in male flies. In concordance with this, studies show that a decline in sex hormones is associated with an increased risk of Alzheimer's in humans.
According to the authors, changes in fat metabolism, digestion, and reproduction are associated with aging. So, the authors hypothesize that tau's presence in neurons may increase the speed of aging throughout the rest of the body.
By measuring gene expression and molecular markers associated with fly aging, the scientists found that tau flies, but not amyloid or control flies, aged more quickly.
Overall, they conclude that 'Tau expression has a broad impact on peripheral tissues and induces an accelerated aging phenotype.'
To understand how tau in neurons has such wide-ranging effects on the body, the scientists used cell-cell communication analysis, which can identify changes in how the brain communicates with the body.
Compared with amyloid and control flies, tau flies demonstrated thousands of differences in these communication pathways. The cell types showing the greatest differences, once again, were involved with fat metabolism, digestion, and reproduction.
These results suggest that tau in the brain can influence cells in the rest of the body by interfering with brain-body communication.
Investigating further, they found that in neurons containing tau, there were changes in the gene expression that affected how synapses — the junction between nerve cells — are organized.
There were also increased levels of synaptic boutons in the gut of tau flies. The synaptic boutons are swellings on nerves at the synapse that contain neurotransmitters, which pass information from one neuron to another.
In other words, tau in brain cells can influence not only how neurons work and develop within the brain but also how effectively they communicate with more distant tissues.
Overall, the scientists conclude that while amyloid and tau are both toxic, their effects are distinct: Amyloid predominantly affects neurons, and tau has a more widespread impact on the body.
They also found that LDH is elevated in amyloid flies, as well as in mice and humans with Alzheimer's. They believe this should be an area for future research, as LDH could perhaps be used as an early biomarker for Alzheimer's.
Research on flies is an important first step in scientific research; it provides direction for future studies on other animals and, eventually, humans.
While we need to interpret the results with caution, taken together, they provide new insights into the widespread effects of Alzheimer's-associated proteins.
'The focus on the peripheral effects of tau and amyloid stands out in this study,' Sawhney told MNT .
'We often think of these proteins as brain-specific problems, but this work highlights how their impact may extend beyond the central nervous system. That's an important shift in perspective for understanding the full systemic nature of dementia.'
— Gurneet Sawhney, MD
Alzheimer's / Dementia
Neurology / Neuroscience
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
10m Americans in multiple US states told to shut windows TODAY as toxic chemicals spark air quality emergency
Officials have issued an air quality alert for around 10 million Americans, telling them to minimize outdoor activities and shut all windows on Tuesday. A National Weather Service (NWS) map shows parts of Minnesota, Michigan, Illinois, New York, Vermont, Indiana and Maine are under advisories until midnight as wildfire smoke from Canada drifts into the US. The alerts stem from elevated levels of ground-level ozone and fine particulates, prompting precautionary measures. In Upstate New York, Vermont, and Maine, residents are advised to limit strenuous outdoor physical activity to mitigate health risks, according to the New York State Department of Health. The NWS has specifically warned residents in northeast Minnesota, eastern Michigan, northeast Illinois and northwest Indiana to keep windows closed overnight to prevent smoke infiltration. Current advisories indicate that ozone levels are not expected to reach 'dangerous' levels (AQI 201 or higher) in any affected region. The highest ozone-related concern is in Michigan's St. Clair to Monroe counties and New York's Niagara to Southern Erie counties, where levels are in the 'Unhealthy for Sensitive Groups' range (AQI 101-150). Other regions are primarily under fine particulate alerts, with no ozone warnings suggesting dangerous conditions, which are small enough to penetrate deep into the lungs and affect the heart. Last week, six US lawmakers wrote to Canada's ambassador, complaining that wildfire smoke drifting south was making it hard for Americans to enjoy the summer. In response, the premier of Manitoba accused them of 'trivializing' a deadly crisis. The fires continue to spread across thousands of acres. May and June were especially destructive in western Canada, where about 30,000 people were forced to evacuate in Saskatchewan and Manitoba, prompting states of emergency in both provinces. In eastern Canada, a wildfire that ignited Monday on Newfoundland's Bonavista Peninsula doubled in size overnight, destroying several cabins near Chance Harbour, according to CBC News. The smoke is now crossing the US border, blanketing millions of Americans. Air quality alerts are in place until 11pm ET several New York counties, including Niagara, Orleans, Monroe, Wayne, Northern Cayuga, Oswego, Jefferson, Northern Erie, Genesee, Wyoming, Chautauqua, Cattaraugus and South Erie. The Air Quality Index (AQI) is expected to exceed 101, signaling potential health risks. Separately, an advisory for fine particulates is active until midnight in Lewis, Livingston, Ontario, and Allegany, including cities such as Lowville, Geneseo, Canandaigua, and Wellsville. Similar alerts for fine particulates, with AQI levels predicted above 100, are in effect from 10 AM to midnight in regions including Northern St. Lawrence, Franklin, Clinton, Essex, and St. Lawrence counties. Northern Herkimer, Hamilton, and Warren counties, including Old Forge and Glens Falls, are also under a fine particulate advisory with the same timeframe. 'When pollution levels are New York State Department of Health recommends that individuals consider limiting strenuous outdoor physical activity to reduce the risk of adverse health effects,' 'People who may be especially sensitive to the effects of elevated levels of pollutants include the very young and those with pre-existing respiratory problems such as asthma or heart disease. 'Those with symptoms should consider consulting their personal physician.' In Michigan, St Clair, Livingston, Oakland, Macomb, Washtenaw, Wayne, and Monroe counties, including cities like Port Huron, Pontiac, Detroit and Ann Arbor are under advisories. However, a statewide Air Quality Alert for fine particulate matter put in place on Monday remains in effect. The Minnesota Pollution Control Agency has issued air quality alerts for northern Minnesota, affecting millions of residents. The alerts cover northeast and northwest/north central Minnesota, with varying levels of concern based on the Air Quality Index (AQI), including counties like Koochiching, St. Louis, Cook, Lake, and Itasca, and cities such as International Falls, Ely, Duluth, Hibbing, and Grand Marais 'Light winds will allow existing wildfire smoke across northern Minnesota to linger into this evening and overnight,' the NWS said. 'Concentrations are expected to be highest along and near the shores of Lake Superior. An additional round of heavy surface smoke from wildfires across southern Canada is expected to transport into northern Minnesota on Tuesday. In Illinois, the Air Pollution Action Day covers McHenry, Lake, Kane, DuPage, Kendall, Grundy, Northern Cook, Central Cook, Southern Cook, Northern Will, Southern Will, and Eastern Will counties. Similarly, northwest Indiana's Air Quality Action Day includes Lake, Porter, Newton, and Jasper counties, encompassing Gary, Hammond, Merrillville, Portage, and Valparaiso. Ozone levels here are also expected to be unhealthy for sensitive groups The Vermont Agency of Natural Resources and the Maine Department of Environmental Protection's Bureau of Air Quality have issued advisories, respectively, affecting millions in the northeastern US. In Vermont, an Air Quality Health Advisory for fine particulates with an AQI approaching or exceeding 151 ('Code Orange') is in place until midnight for Caledonia, Addison, Chittenden, Franklin, Essex, Grand Isle, Lamoille, Orange, Orleans and Washington counties. The advisory in Maine, which lifts at 11pm, covers Northwest Aroostook, Northeast Aroostook, Northern Somerset, Northern Piscataquis, Northern Penobscot, Southeast Aroostook, Central Piscataquis, Central Penobscot, Southern Piscataquis, and Northern Washington counties.


The Independent
2 hours ago
- The Independent
How weight-loss jabs could help lower dementia risk
New research indicates that weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer protection against serious conditions such as dementia and stroke. The study also suggests that individuals with type 2 diabetes and obesity prescribed these medications could face a reduced risk of premature death. Experts from Taiwan conducted a comprehensive study, examining data from 60,000 people worldwide with an average age of 58, all diagnosed with type 2 diabetes and obesity. During a seven-year follow-up, participants given GLP agonist drugs showed a 37 per cent lower risk of dementia, a 19 per cent reduced risk of stroke, and were 30 per cent less likely to die. Academics noted potential neuroprotective and cerebrovascular benefits but called for more studies, including randomised clinical trials, to confirm these findings.


Daily Mail
2 hours ago
- Daily Mail
Ozempic found to slash risk of disease affecting 6.7m Americans each year
Blockbuster weight loss drugs could slash the risk of developing memory-robbing dementia, a major study suggests. Researchers in Ireland analyzed clinical trials of nearly 165,000 taking drugs to lower their glucose (blood sugar) and treat diabetes. The team found most glucose-lowering treatments had no significant impact on dementia risk. However, people taking GLP-1 agonists like Ozempic and Wegovy were 45 percent less likely to develop dementia at some point in their lives than people on other drugs. While it's unclear exactly how the active ingredients in these drugs - most often semaglutide and tirzepatide - reduce the likelihood of dementia, the researchers believe they may lower inflammation in the brain. Neuroinflammation is thought to damage neurons and disrupt communications to part of the brain responsible for memory, triggering dementia symptoms. GLP-1 agonists may also reduce toxic amyloid and tau proteins, hallmarks of dementia. The team suspects GLP-1 agonists like Ozempic may help prevent both diabetes and dementia, both of which are on the rise in the US. Dr Catriona Reddin, senior study author and researcher at the University of Galway, said: 'This research represents a significant contribution to our understanding of how some diabetes medications may impact brain health. 'Diabetes is a known risk factor for dementia, but whether glucose-lowering therapies can help prevent cognitive decline has remained unclear. 'Our findings suggest that GLP-1 receptor agonists, in particular, may have a protective effect on brain health.' The study comes after a similar experiment from the University of Florida, which tracked 400,000 Americans on glucose-lowering drugs and found dementia risk was 33 percent lower for GLP-1 users compared to other interventions. Around 8million adults in the US have some form of dementia, and 500,000 are diagnosed every year. Meanwhile, one in eight US adults has reported taking Ozempic or similar medications at least once for diabetes or weight loss. In the new study, published in JAMA Neurology, researchers identified 26 studies that explored the relationship between GLP-1 agonist use and dementia. These included a total of 164,531 participants, most of whom (65 percent) were men. The average age was 64 with a follow-up time of 31 months. Studies included in the analysis were published between 2015 and 2024. Of the 26 in the review, 10 looked at the impact of GLP-1 agonists. The team suspected GLP-1 agonists may lower inflammation, which is a major driver of dementia. It's thought to activate the immune cells microglia and astrocytes in the brain, which damage neurons and disrupt the blood-brain barrier, the brain's protective layer. GLP-1 agonists have also been shown to lower blood pressure and protect blood vessels, reducing the risk of vascular dementia. A study published in April also found GLP-1s may stimulate neural growth in the hippocampus, an area of the brain responsible for learning and memory formation. However, this research is early. Professor Martin O'Donnell, Dean of the College of Medicine, Nursing and Health Sciences at University of Galway: 'Given the increasing prevalence of both diabetes and dementia, findings from this study have important public health implications for prevention of dementia.' Recent reports from the Alzheimer's Association report rates of Alzheimer's disease - the most common form of dementia - have risen 25 years in a row in the US. Diabetes, meanwhile, affects 12 percent of Americans - 38million. Reports published in 2022 suggest rates in the Americas have tripled in the last 30 years. There were several limitations to the new study, mainly including a lack of data on subtypes of dementia like vascular and Lewy body dementia.